Cargando…
Recent Advancements in Electrochemical Biosensors for Alzheimer’s Disease Biomarkers Detection
BACKGROUND: It is estimated that the average time between the diagnosis of Alzheimer’s disease (AD) and the patient’s death is 5-9 years. Therefore, both the initial phase of the disease and the preclinical state can be included in the critical period in disease diagnosis. Accordingly, huge progress...
Autor principal: | Mikuła, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287894/ https://www.ncbi.nlm.nih.gov/pubmed/33176635 http://dx.doi.org/10.2174/0929867327666201111141341 |
Ejemplares similares
-
Technological advances in electrochemical biosensors for the detection of disease biomarkers
por: Kim, Jae Hyun, et al.
Publicado: (2021) -
Recent Advances in Electrochemical Sensors and Biosensors for Detecting Bisphenol A
por: Tajik, Somayeh, et al.
Publicado: (2020) -
Recent advances in airborne pathogen detection using optical and electrochemical biosensors
por: Sivakumar, Rajamanickam, et al.
Publicado: (2022) -
Recent Advances in Electrochemical Biosensors for Food Control
por: Rizzotto, Francesco, et al.
Publicado: (2023) -
Recent Advances in Electrochemical and Optical Biosensors Designed for Detection of Interleukin 6
por: Khan, Munezza Ata, et al.
Publicado: (2020)